Pure Harvest Corporate Group, Inc. Stock Other OTC
Equities
PHCG
US74625M1018
Pharmaceuticals
Financials (USD)
Sales 2019 | 0.04 | Sales 2020 | 0.74 | Capitalization | 31.42M |
---|---|---|---|---|---|
Net income 2019 | -1M | Net income 2020 | -6M | EV / Sales 2019 | 430,896,057 x |
Net cash position 2019 | 457K | Net Debt 2020 | 2.87M | EV / Sales 2020 | 46,605,076 x |
P/E ratio 2019 |
-15.5
x | P/E ratio 2020 |
-3.88
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 62.22% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Gregarek
CEO | Chief Executive Officer | 44 | 15-07-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Gregarek
CEO | Chief Executive Officer | 44 | 15-07-01 |
1st Jan change | Capi. | |
---|---|---|
+37.08% | 6.01B | |
-17.43% | 4.4B | |
-9.46% | 3.17B | |
+0.51% | 3.07B | |
-3.53% | 2.51B | |
+41.15% | 1.88B | |
-5.15% | 1.73B | |
+0.09% | 1.65B | |
-10.38% | 1.58B |